Management of high-risk non-melanoma skin cancers (NMSC)

Dear BONS Membes,

I’d like to invite you to join a Dana-Farber–anchored, multidisciplinary CME activity focused on the management of high-risk non-melanoma skin cancers (NMSC)—including BCC, cSCC, and Merkel cell carcinoma.

This initiative is designed to bring together the broader Dana-Farber community care team—MDs, APPs, nurses, and pharmacists—to collaborate on real-world cases and align on care strategies across settings.

Dr. Justine Cohen will be leading the discussions, joined by Dana-Farber colleagues across oncology, Mohs surgery, dermatology, and radiation oncology, to guide a series of short, live Zoom conversations focused on peer-to-peer learning and practical collaboration.

Program highlights:

• Non-branded CME (6.0 credits)

• Brief, self-paced modules + patient cases

• Flexible participation—join one or multiple discussions

• Live discussions held May–June (via Zoom)

The goal is to create a shared space for discussion across specialties and roles, reflecting how we care for these patients across the Dana-Farber system and affiliated community settings.

Enroll here: https://medicallogix.gathered.com/invite/v2M0

I hope the team considers joining—it would be great to have your representation.